219 related articles for article (PubMed ID: 31218677)
1. Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB
Chen X; Cowan A; Inan S; Geller EB; Meissler JJ; Rawls SM; Tallarida RJ; Tallarida CS; Watson MN; Adler MW; Eisenstein TK
Br J Pharmacol; 2019 Sep; 176(17):3378-3389. PubMed ID: 31218677
[TBL] [Abstract][Full Text] [Related]
2. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
Burgos E; Pascual D; Martín MI; Goicoechea C
Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia.
Desroches J; Bouchard JF; Gendron L; Beaulieu P
Neuroscience; 2014 Mar; 261():23-42. PubMed ID: 24365460
[TBL] [Abstract][Full Text] [Related]
5. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
Altun A; Yildirim K; Ozdemir E; Bagcivan I; Gursoy S; Durmus N
J Physiol Sci; 2015 Sep; 65(5):407-15. PubMed ID: 25894754
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
8. Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain.
Yuill MB; Hale DE; Guindon J; Morgan DJ
Mol Pain; 2017; 13():1744806917728227. PubMed ID: 28879802
[TBL] [Abstract][Full Text] [Related]
9. CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.
Khasabova IA; Gielissen J; Chandiramani A; Harding-Rose C; Odeh DA; Simone DA; Seybold VS
Behav Pharmacol; 2011 Sep; 22(5-6):607-16. PubMed ID: 21610490
[TBL] [Abstract][Full Text] [Related]
10. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.
Grenald SA; Young MA; Wang Y; Ossipov MH; Ibrahim MM; Largent-Milnes TM; Vanderah TW
Neuropharmacology; 2017 Apr; 116():59-70. PubMed ID: 28007501
[TBL] [Abstract][Full Text] [Related]
11. Topical cannabinoid enhances topical morphine antinociception.
Yesilyurt O; Dogrul A; Gul H; Seyrek M; Kusmez O; Ozkan Y; Yildiz O
Pain; 2003 Sep; 105(1-2):303-8. PubMed ID: 14499448
[TBL] [Abstract][Full Text] [Related]
12. CB
Zheng T; Zhang R; Zhang T; Zhang MN; Xu B; Song JJ; Li N; Tang HH; Wang P; Wang R; Fang Q
Brain Res; 2018 Feb; 1680():155-164. PubMed ID: 29274880
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression.
Inan S; Chen X; Eisenstein EM; Meissler JJ; Geller EB; Tallarida C; Watson M; Doura M; Barrett JE; Cowan A; Rawls SM; Adler MW; Eisenstein TK
Life Sci; 2021 Nov; 285():120014. PubMed ID: 34619167
[TBL] [Abstract][Full Text] [Related]
14. A synergistic analgesic effect of morphine in combination with the CB1 receptor agonist, ACPA, in normal, hypothyroid, and hyperthyroid male rats.
Zarrindast MR; Khakpai F
Acta Neurobiol Exp (Wars); 2023; 83(2):154-170. PubMed ID: 37493532
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid system involves in the analgesic effect of protocatechuic acid.
Dikmen DY; Okcay Y; Arslan R; Bektas N
Daru; 2019 Dec; 27(2):605-612. PubMed ID: 31325037
[TBL] [Abstract][Full Text] [Related]
16. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine.
Garzón J; de la Torre-Madrid E; Rodríguez-Muñoz M; Vicente-Sánchez A; Sánchez-Blázquez P
Mol Pain; 2009 Mar; 5():11. PubMed ID: 19284549
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement.
Spyridakos D; Papadogkonaki S; Dionysopoulou S; Mastrodimou N; Polioudaki H; Thermos K
Neurochem Int; 2021 Jan; 142():104907. PubMed ID: 33220388
[TBL] [Abstract][Full Text] [Related]
19. Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice.
Lee MT; Chen YH; Mackie K; Chiou LC
J Pain; 2021 Mar; 22(3):300-312. PubMed ID: 33069869
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
